General Information of the Compound
Compound ID
CP0137379
Compound Name
4-Benzyl-1-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-piperidine
    Show/Hide
Structure
Formula
C21H25NO2
Molecular Weight
323.436
Canonical SMILES
C(C1COc2ccccc2O1)N1CCC(Cc2ccccc2)CC1
    Show/Hide
InChI
InChI=1S/C21H25NO2/c1-2-6-17(7-3-1)14-18-10-12-22(13-11-18)15-19-16-23-20-8-4-5-9-21(20)24-19/h1-9,18-19H,10-16H2
    Show/Hide
InChIKey
RSDAEFPWFADGBB-UHFFFAOYSA-N
Physicochemical Property
logP
3.7811
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
21.7
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11189143
SID: 16365551
ChEMBL ID
CHEMBL178700
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
Ki = 17.78 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 17.6 nM